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EATING DISORDER – A DIAGNOSIS OF EXCLUSION
PERTURBAÇÃO DO COMPORTAMENTO ALIMENTAR – UM DIAGNÓSTICO DE EXCLUSÃO
ABSTRACT
In adolescents with weight loss, diagnoses other than eating disorders should be considered, namely neurological diseases. A 16-year-old girl 
with an intellectual development disorder was referred to the Adolescent Medicine outpatient clinic from Child Psychiatry with a diagnosis 
of eating disorder and persistent anemia. Her body mass index was consistently below the fifth percentile and long-lasting eating difficulties 
were reported since the age of 15. The girl had no other gastrointestinal, articular, or respiratory complaints, neither polyuria, polydipsia, or 
recurrent fever. Parental divorce and domestic violence were reported. The patient complained of excessive daytime sleepiness, asthenia, 
intermittent myalgia, and muscular weakness episodes. Phenotypic characteristics and personal medical history led to clinical suspicion of 
a neuromuscular disease and genetic study confirmed myotonic dystrophy type 1. This case highlights the importance of considering other 
diagnoses besides eating disorders in adolescents with eating problems. An exhaustive evaluation of personal and family medical history, 
patient complaints, and detailed physical examination is mandatory.
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RESUMO
Em adolescentes com défice de ganho ponderal, devem ser considerados outros diagnósticos para além de perturbações do comportamento 
alimentar, nomeadamente doenças neurológicas. Uma adolescente de 16 anos de idade com perturbação do desenvolvimento intelectual foi 
referenciada da consulta de Pedopsiquiatria para a de Medicina do Adolescente com diagnóstico de perturbação do comportamento alimentar 
e anemia persistente. Apresentava um índice de massa corporal consistentemente abaixo do percentil cinco e dificuldades alimentares 
desde os 15 anos de idade, sem outras queixas gastrointestinais, articulares ou respiratórias e sem poliúria, polidipsia ou episódios de febre 
recorrente. Foi reportado divórcio parental e violência doméstica. A rapariga referia sonolência diurna excessiva, astenia e episódios de 
mialgia intermitente e fraqueza muscular. O fenótipo e a história médica pessoal levaram à suspeita clínica de doença neuromuscular e o 
estudo genético confirmou o diagnóstico de distrofia miotónica tipo 1. Este caso realça a importância de considerar outros diagnósticos para 
além das perturbações do comportamento alimentar em adolescentes com problemas alimentares/de peso. Uma avaliação exaustiva da 
história médica pessoal e familiar e das queixas reportadas pelo doente e um exame físico detalhado são mandatórios.
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INTRODUCTION
Eating disorders (EDs) are complex conditions with profound 
psychosocial and physical consequences, including high mortality 
rate. Despite growing recognition of their prevalence and severity, 
EDs remain underdiagnosed and even misdiagnosed.1 Recognition 
of ED-characteristic clinical presentation is key to distinguish these 
conditions from other important diseases with avoidance/restrictive 
food intake patterns. Pediatricians play an important role in correctly 
identifying these patients, avoiding inadequate treatment and 
properly managing the disease. 
Myotonic dystrophy type 1 (DM1, Steinert’s disease) is 
characterized by autosomal dominant progressive myopathy, muscle 
weakness, and myotonia with multiorgan involvement.  It results 
from a CTG trinucleotide repeat expansion in the 3’-untranslated 
region of the DMPK gene.2 Pathophysiology appears to involve RNA 
toxicity resulting from the expanded repeat in mutant DM1 allele 
transcripts.3 In adulthood, Steinert’s disease is the most frequent 
muscular dystrophy.4
DM1 phenotypical characteristics can be divided into muscular 
and extra-muscular. Muscular features include weakness of facial, 
DM1 
subtype
Clinical manifestations CTG repeat size
Age of onset 
(years)
Lifespan (years)
Congenital
Infantile hypotonia, respiratory failure, feeding difficulty, 
learning problems.
>1000 Birth
45 (neonatal 
deaths not 
included)
Childhood
Cognitive and behavioral problems, low IQ, muscular 
symptoms with disability and possible incontinence.
>800 1 to 10 N/A
Classical
Skeletal and respiratory muscle weakness, myotonia, 
cataracts, cardiac arrhythmias, EDS.
50 to 1000 10 to 30
Reduced (48 to 
60)
Mild Mild weakness, myotonia, or cataracts. 50 to 150 20 to 70 Normal
neck, forearm, hand intrinsic, and foot dorsiflexor muscles, clinical 
myotonia and muscle pain, respiratory muscle affection, dysphagia, 
and dysarthria, which can all contribute to pneumonia or later 
respiratory failure and mastication and trouble eating.2,5-6 Extra-
muscular features include cataracts, progressive cardiomyopathy 
and cardiac conduction disturbances (commonly late in the 
clinical course), cognitive impairment and adulthood personality 
disturbance, endocrine disturbances (like glucose intolerance and 
hypogonadism), and gastrointestinal disorders, like irritable bowel 
symptoms and gall stones.2,7
A systematic DM1 approach should distinguish between four 
disease subtypes: congenital, childhood, classic, and mild (Table 
1). Each subtype severity correlates with CTG repeat expansion, 
despite considerable variability and overlap between DM1 forms.8 
Asymptomatic patients are premutation carriers with a CTG repeat 
size between 38 and 49.2
Muscular problems (dysphagia, mastication difficulty) affecting 
head and neck in DM1 may result in particular eating behaviors, 
which can mislead ED diagnosis, as illustrated in the present clinical 
case. 
Table 1 - Myotonic dystrophy type 1 subtypes based on clinical manifestations, CTG repeat size, age of onset, and life expectancy.8
DM1, myotonic dystrophy type 1; EDS, excessive daytime sleepiness; IQ, intelligence quotient; N/A, not available
CLINICAL CASE
A 16-year-old girl was referred to the Adolescent Medicine 
outpatient clinic (AMC) from Child Psychiatry due to persistent iron 
deficiency anemia. She was diagnosed at the age of 15 years with 
a restrictive-type ED, with depressive behavior and iron deficiency 
anemia. The girl had been treated with sertraline (50 mg daily) for 18 
months and oral iron (III)-polymaltose (375 mg daily) for 16 months. 
She was also followed by a psychologist in primary care setting and by 
a dietitian in hospital setting, as part of ED multidisciplinary approach. 
Patient’s prenatal history comprised premature threatening labor at 
28 weeks of gestation, chronic maternal hypertension, and gestational 
diabetes without need for insulin therapy. No perinatal or neonatal 
health issues were reported. 
Due to learning disabilities and expressive language difficulties, the 
girl was referred to the Pediatric Neurodevelopmental consultation at 
the age of 8. She was tested and revealed a Wechsler Intelligence Scale 
for Children (WISC) intelligence quotient score of 50 with limitations 
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in the practical component of adaptive functioning, being diagnosed 
with moderate Intellectual Developmental Disorder of undetermined 
etiology (normal karyotype and fragile-X testing). Additionally, 
attention deficit hyperactivity disorder (ADHD) was also diagnosed 
and methylphenidate was started. 
Progressive failure to thrive with no stature impact (50th percentile) 
was noted from 6 years old, with weight curves crossing from the 50th 
to the 10th percentile at 12 years and to below the 5th percentile 
at 15 years.  Family described bizarre eating behaviors at the time 
of school initiation (6 years old), including solid food rejection, 
food hiding, easy choking on food, and restrictive/selective food 
preferences. These issues were interpreted as secondary to social 
stress by the general practitioner (GP), who had no clinical suspicion 
of ED at the time, and also disregarded by the girl’s family.
Family dysfunction characterized by domestic violence and alcohol 
abuse resulted in parental divorce at the age of 15 years. 
At 8 years old, the girl began mentioning muscular pain at rest 
(back, shoulders, arms, and lower legs), exercise intolerance/muscle 
weakness, easy fatigue, and excessive day sleepiness.  Sleeping with 
eyes open and mouth breathing were also reported by the family, 
but these signs were again not properly considered by the GP and no 
study was conducted.
The girl’s mother had a history of obesity, cataracts, depression, and 
nephrolithiasis. Maternal second and third-degree relatives were also 
reported to have cataracts, nephrolithiasis, and cardiomyopathy. An 
unclear history of a paternal second-degree relative with muscular 
weakness and/or bones disease was mentioned, but this information 
could not be confirmed. The patient had one only sister with an 
infant son, both apparently healthy. 
In AMC, at the age of 16, the girl had a body mass index (BMI) below 
the 5th percentile. Physical examination revealed thinness, skin 
pallor, nasal tone voice, facial muscle weakness with characteristic 
appearance − ptosis, long and narrow face, hollowed cheeks, and 
jaw sags (Figure 1A) −, clinical myotonia (Figure 1B), and hand 
intrinsic muscle weakness (compromised finger dexterity). Menarche 
occurred at 10 years old and the girl had a 6-month oligomenorrhea 
period. Puberty assessment revealed Tanner stage 5 for breast and 
pubic hair development. She maintained iron deficiency anemia 
diagnosed at 14 years old, when oral iron supplementation was 
started. Hypogonadotropic hypogonadism (luteinizing hormone and 
follicle-stimulating hormone 0.1 IU/L and estradiol inferior to 18.4 
pmol/L) with secondary amenorrhea was diagnosed. A combined 
oral contraceptive (COC) was started due to menstrual irregularities 
and sexual risk. 
Abnormal eating behavior persisted and included time-consuming 
and forced meals, deprecated food, and food hiding. Considering the 
girl’s complaints (namely excessive daytime sleepiness, asthenia, and 
intermittent myalgia episodes), physical exam findings, and family 
history pattern, diagnosis of a muscular condition was considered. 
DMPK gene triplet repeat analysis revealed one normal allele and the 
other with 800-900 trinucleotide (CTG) repeats, confirming myotonic 
dystrophy type 1 (DM1). 
A workup plan for comorbidity evaluation was started based 
on a multidisciplinary evaluation including Cardiology (to 
exclude conduction abnormalities and myocardial dysfunction), 
Ophthalmology (to exclude cataracts), Gynecology (to monitor 
the best contraceptive method), Respiratory/Nose, Throat, and 
Ear evaluation (to monitor pulmonary function and sleep pattern/
disturbance), Endocrinology (to exclude glucose and thyroid 
dysfunction), and Nutrition (to establish adequate diet and nutritional 
rehabilitation).
The patient is currently overall functional, despite some autonomy 
issues regarding daily life activities and self-care. She has good 
communicative skills and recently started a professional degree 
course. 
Figure 1 - Patient phenotype and elicited grip myotonia.
A: Facial and jaw weakness, ptosis, and the typical myopathic or 
‘hatchet’ appearance.
B: Grip myotonia: the examiner instructed the patient to grip her 
fingers firmly and then to let go rapidly. Delayed patient finger 
relaxation discloses myotonia.
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DISCUSSION/CONCLUSION
Considering the patient’s clinical evolution (age of symptom onset, 
muscular and cognitive impairment) and DMPK gene triplet number 
quantification (800 CTG), childhood is the most likely DM1 subtype 
in this case.
Notwithstanding DM1 clinical suspicion, genetic testing for DMPK 
expanded CTG repeat is the diagnostic gold standard. Although not 
always present in younger ages, suggestive myotonic discharge may 
be detected by electromyography as the child ages.2
Despite presenting with suggestive physical and neuropsychological 
signs and symptoms since the age of 6, this patient was never 
investigated for neuromuscular conditions, and the persistent 
feeding and behavior problems were always labeled as ED. 
There is currently no disease-modifying therapy available for 
DM1, although potential genetic treatments seem promising in 
a near future.2,8 Disease prognosis (life expectancy) depends on 
DM1 subtype (Table 1), but multidisciplinary follow-up and close 
surveillance for possible clinical complications seem to be of upmost 
importance. Annual electrocardiograms should be part of routine 
management.2
Genetic counseling is mandatory due to the 50% possibility of 
offspring disease inheritance (usually with increased CTG repeat 
number, disease severity, and age of onset anticipation), allowing a 
timely approach to potential comorbidities.2
This case highlights the need for a high index of clinical suspicion for 
diagnosing specific conditions through anamnesis, clinical exam, and 
multidisciplinary approach. 
Although this neurological disorder could have been easily 
overseen in early development stages, it became increasingly evident 
throughout the years and its recognition could have prevented 
misdiagnosis and unnecessary treatments. Time from symptom 
onset, prolonged clinical course, absence of growth affectation 
(height and puberty), and presence of physical particularities should 
have triggered DM1 diagnosis at an earlier stage. 
 COCs are not indicated in amenorrheic adolescent girls with ED, 
as they can be associated with body changes.9,10 Regarding patient-
related concerns (described above), earlier and correct diagnosis 
could have allowed to propose other (non-hormonal) contraceptive 
methods. 
 Family complaints, present and past medical history − including 
learning disorders, feeding history, and any related issues −, 
performance in daily routine activities, and a detailed physical and 
neurological medical examination should be part of patient approach.
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